Optimizing outcomes in clozapine rechallenge following neutropenia using human leukocyte antigen typing: A case report

Psychiatry Clin Neurosci. 2017 Apr;71(4):289-290. doi: 10.1111/pcn.12505. Epub 2017 Mar 11.

Authors

Naruhisa Yamaki¹, Akitoyo Hishimoto¹, Ikuo Otsuka¹, Toru Sasada², Shuken Boku¹, Takeo Saito³, Yuka Yasuda^{4

5}, Hidenaga Yamamori⁴, Masashi Ikeda³, Manabu Ikeda⁴, Ichiro Sora¹, Nakao Iwata³, Ryota Hashimoto^{4

5}

Affiliations

¹ Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe, Japan.
² Osaka Psychiatric Medical Center, Hirakata, Japan.
³ Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.
⁴ Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan.
⁵ Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Suita, Japan.

PMID: 28097743
DOI: 10.1111/pcn.12505

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antipsychotic Agents / administration & dosage
Antipsychotic Agents / adverse effects*
Clozapine / administration & dosage
Clozapine / adverse effects*
Female
HLA Antigens / blood*
Histocompatibility Testing*
Humans
Neutropenia / chemically induced*
Schizophrenia, Paranoid / blood
Schizophrenia, Paranoid / drug therapy*
Schizophrenia, Paranoid / immunology

Substances

Antipsychotic Agents
HLA Antigens
Clozapine